Divi's Laboratories
Search results
pharmaceutical ingredients. and finished dosages. Best-in-class, future-ready facilities staffed by meritorious personnel. Committed to sustainable, efficient, and scalable operations. Core emphasis on safety, environment, and society. Press releases and announcements. 25 Apr 2024.
As a research-driven pharmaceutical manufacturing organization, Laurus Labs has been developing and assisting its client organizations to succeed in innovative medicines that globally enhance the health outcomes for patients.
Laurus Labs Pvt. Ltd. is engaged in the developing, manufacturing, and supplying pharmaceutical ingredients and related intermediates to the global pharmaceutical industry.
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations , custom synthesis (CDMO), biotechnology , [7] veterinary APIs and agrochemicals .
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics.
Get the latest Laurus Labs Ltd (LAURUSLABS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Laurus Labs features among India’s Best Workplaces in the Biotechnology & Pharmaceutical category . Read More
5 days ago · Shares of Laurus Labs Ltd. recovered from the day's low of ₹ 418.05 after the pharmaceutical company said that it remains committed to the financial year 2025 outlook. The company reported its financial results for the first quarter of FY25 below the Street expectations. NSE. Laurus Labs reported a 50% year-on-year decline in net profit at ...
Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry.
Sep 14, 2015 · Laurus Labs is targeting a Rs 2,000-crore topline in eight years. Even in the profitable pharmaceutical business, such a rapid pace is not seen very often.
